OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.
OXB expands BMS partnership to churn out lentiviral vectors for commercial CAR-Ts
Latest from Blog
Loneliness, Isolation Can Strip Away Years Of Healthy Life, Large Study Finds
Post Content Post Views: 0
Stroke Rates Nearly Double In Younger Adults
Post Content Post Views: 0
Federal judge rolls back landmark disability protections
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Chelsea Cirruzzo filling in here today from D.C., where another fox has
How The MIND Diet Protects Aging Brains
Post Content Post Views: 0
Keeping A Steady Job Might Help You Stay Sharp Later In Life
Post Content Post Views: 0